Exagen Inc. (XGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.66
-2.20%
Mkt Cap $76.60M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$13.00
Range $9.00 – $15.00
Implied Upside
+388.7%
Consensus $13.00 vs current $2.66
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.66
-2.20%
Mkt Cap $76.60M
No recent rating data.
Price Target (9 analysts)
$13.00
Range $9.00 – $15.00
+388.7%
Consensus $13.00 vs current $2.66